Color
Total Raised
$496.04MInvestors Count
27Deal Terms
5Funding, Valuation & Revenue
9 Fundings
Color has raised $496.04M over 9 rounds.
Color's latest funding round was a Series E for $100M on November 9, 2021.
Color's valuation in January 2021 was $1,333 - $1,500M.
Color's latest post-money valuation is from November 2021.
Sign up for a free demo to see Color's valuations in November 2021 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
11/9/2021 | Series E | $100M | 22 | |||
1/4/2021 | Series D | $1,333 - $1,500M | ||||
1/15/2020 | Series C - III | |||||
8/21/2019 | Grant | |||||
11/14/2017 | Series C - II |
Date | 11/9/2021 | 1/4/2021 | 1/15/2020 | 8/21/2019 | 11/14/2017 |
|---|---|---|---|---|---|
Round | Series E | Series D | Series C - III | Grant | Series C - II |
Amount | $100M | ||||
Investors | |||||
Valuation | $1,333 - $1,500M | ||||
Revenue | |||||
Sources | 22 |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Color Deal Terms
5 Deal Terms
Color's deal structure is available for 5 funding rounds, including their Series E from November 09, 2021.
Round | Series E | Series D | Series C | Series B | Series A |
|---|---|---|---|---|---|
Funding Date | |||||
Pre-Money Valuation | |||||
Post-Money Valuation | |||||
Amount Raised | |||||
Shares Authorized | |||||
Issuance Price | |||||
Dividend Rate | |||||
Liquidation Preferences | |||||
Liquidation Price | |||||
Participation | |||||
Conversion Price | |||||
Anti Dilution | |||||
General Voting | |||||
Board Voting | |||||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series E | |||||||||||||||
Series D | |||||||||||||||
Series C | |||||||||||||||
Series B | |||||||||||||||
Series A |
Color Investors
27 Investors
Color has 27 investors. General Catalyst invested in Color's Series E funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
8/29/2016 | 11/9/2021 | 5 Series B, Series C (2017), Series C - II (2017), Series D (2021), Series E (2021) | Venture Capital | California | ||
8/29/2016 | 11/9/2021 | 3 Series B, Series C (2017), Series E (2021) | Family Office | California | ||
1/15/2020 | 11/9/2021 | 3 Series C - III, Series D (2021), Series E (2021) | Asset/Investment Management | New York | ||
Asset/Investment Management | Maryland | |||||
Venture Capital | California |
First funding | 8/29/2016 | 8/29/2016 | 1/15/2020 | ||
|---|---|---|---|---|---|
Last Funding | 11/9/2021 | 11/9/2021 | 11/9/2021 | ||
Investor | |||||
Rounds | 5 Series B, Series C (2017), Series C - II (2017), Series D (2021), Series E (2021) | 3 Series B, Series C (2017), Series E (2021) | 3 Series C - III, Series D (2021), Series E (2021) | ||
Board Seats | |||||
Type | Venture Capital | Family Office | Asset/Investment Management | Asset/Investment Management | Venture Capital |
Location | California | California | New York | Maryland | California |
Color Acquisitions
1 Acquisition
Color acquired 1 company. Their latest acquisition was Mood Lifters on October 27, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
10/27/2022 | Acquired | 2 |
Date | 10/27/2022 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources | 2 |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare Color to Competitors
OmeCare provides physicians and their patients with genetic information to improve or maintain health and wellness. The company's mobile health applications merge artificial intelligence and deep learning with personal genetic information that provides personalized health and wellness guidance.
Everly Health is a digital health platform specializing in diagnostics-driven care and the healthcare sector. The company offers at-home testing kits and digital tools for diagnosing and managing recurring health conditions, providing results online. Everly Health primarily serves the healthcare ecosystem, including individual consumers and enterprise clients. Everly Health was formerly known as Everly Well. It was founded in 2015 and is based in Austin, Texas.
healthPrecision focuses on enhancing healthcare delivery through its artificial intelligence (AI)-powered platform, Medical Brain, which operates in the healthcare technology sector. The company offers a clinical decision support system that engages with patients and healthcare providers to identify health risks and care gaps, providing real-time actionable insights to improve health outcomes and prevent unnecessary emergency room visits. Medical Brain serves various healthcare sectors, including chronic disease management, radiology, infectious diseases, and maternal health, by offering evidence-based clinical modules and guidelines. It was founded in 2017 and is based in New York, New York.
RhythmX AI focuses on providing primary care decision-making through its artificial intelligence (AI) powered precision care platform within the healthcare technology sector. The company offers a suite of tools for physicians, including advanced patient risk stratification, AI-driven care recommendations, and intelligent workflow optimization to deliver hyper-personalized and compassionate care. RhythmX AI primarily serves the healthcare industry, enhancing the capabilities of doctors, hospitals, and healthcare providers with its technology. It was founded in 2023 and is based in Palo Alto, California.
Genomelink is a personal genomics company that provides Deoxyribonucleic acid(DNA) analysis and insights. The company offers a platform for users to upload their raw DNA data to receive a wide range of reports on ancestry, wellness, and personal traits. Genomelink targets individuals interested in exploring their genetic makeup and gaining personalized insights into their health, ancestry, and personal characteristics. It was founded in 2017 and is based in Berkeley, California.
Palta develops a range of application-based products in the digital health segment. It provides insights into the health and behavioral habits of customers and helps them detect health problems through artificial intelligence (AI) systems. Its applications focus on preventative healthcare and well-being. It was formerly known as Haxus Ventures. It was founded in 2016 and is based in London, United Kingdom.
Loading...